GeneTex
  • Country / Location Selection

United States (US)

SETDB2 blocking peptide

Cat No. GTX13712-PEP

Species

Human
Package
100 μg ($239)

APPLICATION

Product Note

The peptide was used in the production of GTX13712.

PROPERTIES

Form

Lyophilized powder

Buffer

Lyophilized from 5% (v/v) acetonitrile/H₂O. Reconstitute pellet in 200μl distilled water to obtain a 0.5mg/ml peptide solution.

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Region/Sequence

GEKNGDAKTFWME-C

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

TARGET

Synonyms

Set Domain Bifurcated 2 , C13Orf4 , Clld8 , Clll8 , Kmt1F , Setdb2

Background

Proteins that contain a SET domain, such as SETDB2, modulate gene expression epigenetically through histone H3 (see MIM 601128) methylation. SETDB2 is likely a histone H3 methyltransferase, as it contains both the active site and flanking cysteine residues required for catalytic activity (Zhang et al., 2003 [PubMed 12754510]).[supplied by OMIM, Mar 2008]

Research Area

REFERENCE

There are currently no references for SETDB2 blocking peptide (GTX13712-PEP). Be the first to share your publications with this product.

REVIEW

There are currently no reviews for SETDB2 blocking peptide (GTX13712-PEP). Be the first to share your experience with this product.